Public Charity

THE OSTEOSARCOMA INSTITUTE

THE OSTEOSARCOMA INSTITUTE, of DALLAS, TX, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $4.2M in revenue, $2.7M in expenses, $6.3M in total assets. 27 publicly reported grants to this organization, totaling roughly $4.8M, appear in IRS filings.

EIN: 822921815 DALLAS, TX Research Institutes & Public Policy Analysis NTEE: H05 Latest filing: 2024
Total Revenue$4.2M
Total Expenses$2.7M
Total Assets$6.3M
Grant Records27
Funding Total$4.8M
Filing Years2019–2024

Mission

THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.

Where $100 goes at The Osteosarcoma Institute

How The Osteosarcoma Institute divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.

$75 Programs the work itself
$12 Management running the organization
$13 Fundraising raising the next dollar

Inside the $75 for programs

$15
Other program services expenditures not directly allocable to the twelve on-going research grants during the current year including expenditures of $18,821 for the osi connect program
21% of program spending
$11
The Osteosarcoma Institute executed agreements to fund two grants for a total of $1,300,000 for a clinical trial and correlative study with the dana farber cancer institute
15% of program spending
$10
The Osteosarcoma Institute executed an agreement to fund a translational research grant for a total of $500,000 with bc cancer
14% of program spending

Plus 8 more programs. Cost per person served and the full program breakdown are on the full profile.

Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

BOARD OF TRUSTEES Alli Murdoff
INSTITUTE DIRECTOR Lee Helman
BOARD OF TRUSTEES Lisa Tichenor
BOARD OF TRUSTEES Mary Katherine Clarke
CHAIR OF BOARD OF TRUSTEES Mchenry Tichenor Jr
BOARD OF TRUSTEES Michael Egge

Officer compensation and complete director data available with membership.

Top Grant Purposes

General Support
$4,099,127 19 grants
Health & Medicine
$556,669 6 grants
Research & Policy
$112,350 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $4.2M $2.7M $6.3M
2023 $1.4M $2.7M $4.8M
2022 $750K $1.4M $6.1M
2020 $454K $1.1M $8.3M
2019 $376K $341K $9.0M

Between 2019 and 2024, reported annual revenue grew from $376K to $4.2M (+1009%), with total assets most recently reported at $6.3M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for THE OSTEOSARCOMA INSTITUTE

Complete financials, all 27 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time